Growth stimulation of human head and neck squamous cell carcinoma cell lines by interleukin 4

Clinical Cancer Research

Volumn 2, Issue 1, 1996, Pages 127-135

  Myers, Jeffrey N ^a,e   Yasumura, Satoshi ^a,d   Suminami, Yoshinori ^a,d   Hirabayashi, Hideki ^a,d   Lin, Wen Chang ^a,d   Johnson, Jonas T ^a   Lotze, Michael T ^a,b,c,d   Whiteside, Theresa L ^a,d  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^e University of Pittsburgh School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 4;

ARTICLE; CANCER CELL CULTURE; CELL GROWTH; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

CARCINOMA, SQUAMOUS CELL; CELL DIVISION; FLOW CYTOMETRY; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-4; RECEPTORS, INTERLEUKIN-4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0030051726     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Weidmann, E., Sacchi, M., Plaisance, S., Heo, D. S., Yasamura, S., Lin, W-c., Johnson, J. T., Herberman, R. B., Azzarone, B., and Whiteside, T. L. Receptors for interleukin 2 on human squamous cell carcinoma cell lines and tumor in situ. Cancer Res., 52: 5963-5970, 1992.
2. Rabinowich, H., Vitolo, D., Altarac, S., Herberman, R. B., and Whiteside, T. L. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL2-activated natural killer cells. J. Immunol., 149: 340-349, 1992.
3. Yasumura, S., Lin, W-c., Weidmann, E., Hebda, P., and Whiteside, T. L. Expression of interleukin 2 receptors on human carcinoma cell lines and tumor growth inhibition by interleukin 2. Int. J. Cancer, 59: 225-234, 1994.
4. Banchereau, J., Briere, F., Galizzi, J. P., Miossec, P., and Rousset, F. Human interleukin 4. J. Lipid Mediat. Cell Signal., 9: 43-53, 1994.
5. Lotze, M. T. Clinical protocol: the treatment of patients with melanoma using interleukin-2, interleukin-4, and tumor infiltrating lymphocytes. Hum. Gene Ther., 3: 167-177, 1992.
6. Puri, R. K., Ogata, M., Leland, P., Feldman, G. M., Fitzgerald, D., and Pastan, I. Expression of high-affinity interleukin-4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin. Cancer Res., 51: 3011-3017, 1991.
7. Totpal, K., and Aggarwal, B. B. Interieukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines. Cancer Res., 51: 4266-4270, 1991.
8. Hoon, D. S. B., Okun, E., Banez, M., Irie, R. F., and Morton, D. L. Interieukin 4 alone and with γ-interferon or α-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas. Cancer Res., 51: 5687-5693, 1991.
9. Obiri, N. I. and Hillman, G., Haas, G. Sudha, S., and Puri, R. K. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4. J. Clin. Invest., 91: 88-93, 1993.
10. Morisaki, T , Yuzuki, D. H., Lin, R. T., Foshag, L. J., Morton, D. L., and Hoon, D. S. B. Interieukin 4 receptor expression and growth inhibition of gastric carcinoma cells by interleukin 4. Cancer Res., 52: 6059-6065, 1992.
11. Obiri, N. I., Siegel, J. P., Varrichio, F., and Puri, R. K. Expression of high affinity interleukin-4 receptors on human melanoma, ovarian, and breast carcinoma cells. Clin. Exp. Immunol., 95: 1248-1255, 1994.
12. Obiri, N. I., and Puri, R. K. Characterization of interleukin-4 receptors expressed on human renal cell carcinoma cells. Oncol. Res., 6: 419-427, 1994.
13. Manabe, A., Coustan-Smith, E., Kumagi, M., Behm, F. G., Raimondi, S. C., Pui, C-H., and Campana, D. Interleukin-4 induces programmed cell death (apoptosis) in cases of high-risk acute lymphoblastic leukemia. Blood, 84: 1731-1737, 1994.
14. Defrance, T., Fluckiger, A-C., Rossi, J-F., Magaud, J-P., Sotto, J-J., and Banchereau, J. Antiproliferative effects of interleukin-4 on freshly isolated non-Hodgkin malignant B-lymphoma cells. Blood, 79: 990-996, 1992.
15. Yasumura, S., Hirabayashi, H., Schwartz, D. R., Toso, J. F., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Human cytotoxic T-cell lines with restricted specificity for squamous cell carcinoma of the head and neck. Cancer Res., 53: 1461-1468, 1993.
16. Heo, D. S., Snyderman, C., Gollin, S. M., Pan, S., Walker, E., Deka, R., Barnes, E. L., Johnson, J. T., Herberman, R. B., and Whiteside, T. L. Biology, cytogenetics and sensitivity to immunological effector cells of new head and neck squamous cell carcinoma lines. Cancer Res., 49: 5167-5175, 1989.
17. Heo, D. S., Park, J-G., Hata, K., Day, R., Herberman, R. B., and Whiteside, T. L. Evaluation of tetrazolium-based semiautomatic colonmetric assay for measurement of human anutumor cytotoxicity. Cancer Res., 50: 3681-3690, 1990.
18. Vitolo,. D., Vujanovic, N., Rabinovuch, H., Schlesinger, M., Herberman, R. B., and Whiteside, T. L. Rapid interleukin-2 induced adherence of human natural killer (NK) cells II. Expression of mRNA for cytokines and IL2 receptors in adherent NK cells. J. Immunol., 151: 1926-1937, 1993.
19. Taylor C. W., Grogan T. M., Salmon, S. E. Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms. Blood, 79: 990-996, 1992.
20. Keegan, A. D., Wang, L. M., and Pierce, J. H. Characterization of the interleukin 4 receptor. Structure and signal transduction pathways. Res. Immunol., 144: 590-596, 1993.
21. Izuhara, K., Yang, G., Miyajima, A., Howard, M., and Harada, N. C Structure of the IL4 receptor and signal transduction mechanism of IL4 Res. Immunol., 144: 584-590, 1993.
22. Keegan, A. D., and Pierce, J. H. The interleukin-4 receptor: signal transduction by a hematopoietic receptor. J. Leukocyte Biol., 55: 272-279, 1994.
23. Izuhara, K., and Harada, N. Interleukin-4 (IL-4) induces protein tyrosine phosphorylation of the IL4 receptor and association of phosphatidylinositol 3-kinase to the IL4 receptor in a mouse T cell line, HT2. J. Biol. Chem., 268: 13097-13102, 1993.
24. Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Liu, E. T, and Ihle, J. N. Involvement of the JAK-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature (Lond.), 370: 153-157, 1994.
25. Yin, T., Tsang, M. L., and Yang, Y. C. JAK 1 kinase forms complexes with interleukin-4 receptor and 4PS/insulin receptor substrate-1-like protein and is activated by interleukin-4 and interleukin-9 in T lymphocytes. J. Biol. Chem., 269: 26614-26617, 1994.
26. Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M., and McKnight, S. L An interleukin-4-induced transcription factor: IL4 STAT. Science (Washington DC), 265: 1701-1706, 1994.
27. Lin, W-c., Yasumura, S., and Whiteside, T. L. Transfer of IL2 receptor genes into squamous cell carcinoma-modification of tumor cell growth. Arch. Otolaryngol. Head & Neck Surg., 119: 1229-1235, 1993.
28. Russell, S. M., Keegan, A. D., Harada, N., Nakamura, Y., Noguchi, M., Leland, P., Friedmann, M. C. Miyajima, A., Puri, R. K., and Paul, W. E. Interleukin-2 receptor γ chain: a functional component of the interleukin-4 receptor. Science (Washington DC), 262: 1880-1883, 1993.
29. Kondo, M., Takeshita, T., Ishii, N., Nakamura, M., Watanabe, S., Arai, K., and Sugamura, K. Sharing of the interleukin-2 (IL-2) receptor γ chain between receptors for the IL2 and IL4. Science (Washington DC), 262: 1874-1877, 1993.
30. Grandis, J. R., and Tweardy, D. J. Elevated levels of transforming growth factor-α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res., 53: 3579-3584, 1993.